when were glp 1 agonists approved Glucagon-like peptide-1 receptor: mechanisms and advances in therapy History of glucagon-like peptide-1 receptor

Evidence is emerging that glucagon-like peptide-1 (GLP-1) receptor agonists have anti-inflammatory and chondroprotective properties independent of their effects on weight loss

Tirzepatide was more efficacious in reducing body weight

A new study found that the cost of GLP-1 drugs like Wegovy and Zepbound is too high to justify their benefits

Shima Hadidchi MD Offered Semaglutide GLP-1 Injections to Help Obese Adults to Achieve Substantial Weight Loss & Improved Overall Health.

Lets separate guesses from facts.

While these agents are not recommended during pregnancy, their use in the preconception, periconception, and postpartum periods is increasing